Ann: Results of Phase 2 Clinical Trial, page-131

I got carried away with LCT last year smashed over $100k .
How many times does it happen,, well not as drastic as FTT etc but only 5% of Biotechs manage to commercialise a product and provide a financial return for shareholders...

Now I only trade Inflection Points and Catalyst moments,, in and out thanks win quick ,lose quick either way...

There are 3 main sweet spots in Biotech,, completion of Phase I " They Have Something" Run Up to Phase II,, current shareholders wanting to build on their holding and FOMO crew who just heard about the company..
Interim Results from Phase II really give a shot of confidence so expect a spike here..

lastly as it crosses the finish line Phase III or T/O or mega licensing Deal.

Now I only invest in Biotech that generating income,, I dont care how much but it demonstrates the ability to commercialise something and that the burden of constant CR's is reduced,,plus if it goes toes up on a pipeline product it still has its income from the commercialised tech.

Those that I really get behind I go in fairly heavy, early and try and free carry as much as i can through Phase II.

I feel for those that have lost money on this company,,, especially those that were long termers...